Cancer Epidemiology Biomarkers & Prevention: review time and acceptance speed

ISSN 1055-9965 · ISSN 1538-7755 · American Association for Cancer Research · Medicine

Half of the articles Cancer Epidemiology Biomarkers & Prevention accepted in 2025 were accepted within 127 days of submission (n = 253); the middle half took 102–167 days.

Submission → acceptance (2025)
127 days median
middle half 102–167 · n = 253
Change since 2023
No clear change since 2023 (median 123 → 127 days; 90% CI -6 to +15 days).
Open access · fees
Hybrid · no listed APC found

Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026

Plan submissions to a deadline — free

How long does Cancer Epidemiology Biomarkers & Prevention take to accept a paper?

days0601201802402020: middle half 101–162 days1262020n=2942021: middle half 110–170 days1352021n=2502022: middle half 103–166 days1262022n=2192023: middle half 93–160 days1232023n=1922024: middle half 106–157 days1282024n=1962025: middle half 102–167 days1272025n=253
Line = median; shaded box = middle half of articles (25th–75th percentile). Year of acceptance.
Days from submission to acceptance, by year of acceptance
YearArticles (n)25th pctMedian75th pct90th pctAccepted <14 daysHave a revised date
20252531021271672020.8%100%
20241961061281571.5%99%
2023192931231600.0%100%
20222191031261661980.5%99%
20212501101351702060.8%100%
20202941011261622021.0%100%

Distribution in 2025

0–29 days: 3% (7 articles)030–59 days: 3% (7 articles)3060–89 days: 11% (28 articles)6090–119 days: 24% (61 articles)90120–149 days: 27% (68 articles)120150–179 days: 15% (38 articles)150180–209 days: 9% (22 articles)180210–239 days: 4% (10 articles)210240–269 days: 2% (6 articles)240270–299 days: 1% (3 articles)270300–329 days: 0% (1 articles)300330–359 days: 0% (1 articles)330360+ days: 0% (1 articles)360+days from submission to acceptance (30-day bins)
Show as a table
DaysArticlesShare
0–2972.8%
30–5972.8%
60–892811.1%
90–1196124.1%
120–1496826.9%
150–1793815.0%
180–209228.7%
210–239104.0%
240–26962.4%
270–29931.2%
300–32910.4%
330–35910.4%
360+10.4%

From acceptance to online publication

Not enough articles with both an acceptance date and an online publication date to measure the time to online publication.

Read these numbers carefully

  • These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
  • Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
  • Invited articles and special issues can move faster than regular submissions.

Open access status and publishing fees

Hybrid (subscription journal with an open-access option). No listed APC found in DOAJ or OpenAlex. That does not mean publishing is free — check the journal's author guidelines.

OpenAPC has fewer than 5 reported payments for this journal in 2023–2025, so no typical amount is shown.

Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.

Integrity and indexing signals

Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.

Listed in DOAJNo
Articles indexed for MEDLINE in 2025Yes
Retractions0 retracted articles among 1,113 added to PubMed in 2021–2025 (0.00 per 1,000), per the Retraction Watch Database.
Accepted within 14 days of submission0.8% of 2025 articles
Publication volume251 articles added to PubMed in 2025 (+29% vs 2024).

Topics and scope

Medicine journalsBiochemistry, Genetics and Molecular Biology journalsOncology journals

Similar journals — faster or cheaper, side by side

Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2025 figures are compared with the 2025 median of Cancer Epidemiology Biomarkers & Prevention, 127 days.

Paid APC medianDOAJMEDLINE
Cancer Causes & Control130 (2025, n = 162)≈$3,890NoYes
Cancer Epidemiology86 (2025, n = 187)≈$3,740NoYes
JNCI Cancer Spectrum118 (2025, n = 122)$1,951YesYes
Cancer Prevention Research155 (2025, n = 71)NoYes
Journal of Cancer Policy82 (2025, n = 106)≈$2,760NoYes
Journal of Cancer Education59 (2025, n = 88)≈$3,790NoYes
JNCI Journal of the National Cancer Institute98 (2025, n = 350)≈$5,436NoYes
The Lancet Oncology60 (2025, n = 265)≈$7,280NoYes
Current Oncology45 (2025, n = 692)≈$2,689$2,146 (29 payments)YesYes

Frequently asked questions

How long does Cancer Epidemiology Biomarkers & Prevention take to accept a paper?

Half of the articles Cancer Epidemiology Biomarkers & Prevention accepted in 2025 were accepted within 127 days of submission (n = 253); the middle half took 102–167 days. Based on dates in PubMed for accepted articles only.

Does Cancer Epidemiology Biomarkers & Prevention charge an article processing charge (APC)?

No listed APC found in DOAJ or OpenAlex. That does not mean publishing is free — check the journal's author guidelines.

Sources and method

Journal identity: ISSN-L 1055-9965; NLM ID 9200608; OpenAlex record. Speed figures use 253 articles accepted in 2025 with valid dates; excluded records for that year: none.

Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.

Get the free Journal Submission Go/No-Go Checklist

The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.

One email with your download, then occasional research tips. One-click unsubscribe, anytime. We never sell your data.

Get Write and Publish a Scientific Paper

Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.